Vera Therapeutics Inc (VERA)
41.38
-0.56
(-1.34%)
USD |
NASDAQ |
May 17, 16:00
41.38
0.00 (0.00%)
After-Hours: 20:00
Vera Therapeutics Free Cash Flow (Quarterly): -33.83M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.83M |
| December 31, 2023 | -25.14M |
| September 30, 2023 | -22.97M |
| June 30, 2023 | -17.77M |
| March 31, 2023 | -26.29M |
| December 31, 2022 | -21.16M |
| September 30, 2022 | -18.46M |
| June 30, 2022 | -19.04M |
| March 31, 2022 | -8.999M |
| Date | Value |
|---|---|
| December 31, 2021 | -6.438M |
| September 30, 2021 | -5.484M |
| June 30, 2021 | -7.665M |
| March 31, 2021 | -4.121M |
| December 31, 2020 | -27.38M |
| September 30, 2020 | -2.447M |
| June 30, 2020 | -2.722M |
| March 31, 2020 | -2.357M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-33.83M
Minimum
Mar 2024
-2.357M
Maximum
Mar 2020
-14.84M
Average
-17.77M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 1.058B |
| Alpine Immune Sciences Inc | -27.71M |
| Fate Therapeutics Inc | -33.44M |
| Mersana Therapeutics Inc | -32.79M |
| Equillium Inc | -8.819M |